Study guide

12.1 Waived and POC Instrument Operation

ASCP Medical Laboratory Assistant MLA

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the ASCP MLA Exam 1.2 Eligibility Routes and Study Plan

2 Chapter 2: Orders, Identification & Communication

2.1 Review, Clarification, and Verification of Test Orders 2.2 Patient Identification 2.3 Patient Communication

3 Chapter 3: Collection Procedures

3.1 Patient Assessment and Preparation 3.2 Site Selection 3.3 Tubes, Anticoagulants, and Order of Draw 3.4 Specimen Types for Common Tests

4 Chapter 4: Special Collections, Reactions & Handling

4.1 Special Collection Procedures 4.2 Adverse Collection Reactions 4.3 Specimen Labeling and Immediate Handling

5 Chapter 5: Specimen Acceptability Assessment

5.1 Correct Specimen Type for the Test 5.2 Specimen Quality Assessment 5.3 Labeling Requirements and Rejection Criteria 5.4 Time, Temperature, and Light Handling

6 Chapter 6: Add-on Requests & Special Specimen Types

6.1 Specimen Suitability for Add-on Requests 6.2 Special Specimen Types

7 Chapter 7: Prioritization, Distribution & Transport

7.1 Department Distribution and Prioritization 7.2 Pneumatic Tube System 7.3 External Packaging and Shipment

8 Chapter 8: Specimen Processing Techniques

8.1 Centrifugation 8.2 Aliquoting 8.3 Non-Blood Specimen Processing 8.4 Microbiology Setup and Plating

9 Chapter 9: Slide Preparation & Specimen Storage

9.1 Slide Preparation 9.2 Specimen Storage (Pre- and Post-Testing)

10 Chapter 10: Reagents, Instrumentation & Quality Control

10.1 Reagents, Standards, and Controls 10.2 Analytical Instrumentation 10.3 Quality Control

11 Chapter 11: Critical Values, Results & Inventory

11.1 Critical Value Notification and Documentation 11.2 Result Retrieval and Review 11.3 Inventory Management

12 Chapter 12: Waived & Point-of-Care Testing

12.1 Waived and POC Instrument Operation 12.2 Waived/POC QC, Result Evaluation & Reporting

13 Chapter 13: Laboratory Regulations, Chemical & Fire Safety

13.1 Laboratory Regulations 13.2 Chemical Safety 13.3 Fire Safety

14 Chapter 14: Infection Control & Waste Disposal

14.1 Standard Precautions, PPE & Hand Hygiene 14.2 Biological Safety Cabinets, Sharps & Exposure Control 14.3 Biological and Hazardous Waste Disposal

15 Chapter 15: Equipment, Ethics, LIS & Quality Assurance

15.1 Laboratory Equipment Maintenance 15.2 Professionalism, Ethics & HIPAA 15.3 Laboratory Information System (LIS) Functions 15.4 Quality Assurance and Improvement

12.1 Waived and POC Instrument Operation

Key Takeaways Explain This Topic AI

CLIA waived tests are simple procedures with a low risk of erroneous results when performed correctly; they still require following the manufacturer instructions for use (IFU) and facility SOP exactly.

Common waived/POC tests the MLA may support include glucose meters, urine dipsticks, urine hCG, rapid strep and respiratory antigen tests, FOBT, some POC coagulation devices, and certain POC HbA1c systems—always confirm your site’s CLIA-waived menu.

Reagents and kits must be stored at the labeled temperature, used within expiration and open-vial stability, and never mixed across lots or kits unless the IFU allows it.

Operator competency (training, observation, periodic assessment) and positive patient identification with two identifiers before testing are non-negotiable patient-safety steps.

Device cleaning and routine maintenance follow the manufacturer schedule; a dirty or poorly maintained meter is a quality failure even when reagents look fine.

Last updated: August 2026

12.1 Waived and POC Instrument Operation

Quick Answer: CLIA waived tests are simple methods with low risk of erroneous results when done correctly . Operate every device and kit exactly per the manufacturer IFU and your SOP , store reagents correctly, maintain and clean devices, prove operator competency , and identify the patient with two identifiers before any fingerstick, urine cup, or cartridge is run.

Waived and point-of-care (POC) testing sits in Domain III: Support for Clinical Testing under the ASCP MLA content guideline for testing dates beginning June 1, 2026 (outline letter G ). The earlier guideline, valid only through May 31, 2026, listed waived/POC as a separate small domain; current exams fold this work into Domain III alongside reagents, instruments, QC, results support, and inventory. Expect scenario questions about glucose meters, urine dipsticks, pregnancy kits, rapid antigen tests, and what the MLA must never improvise.

What “CLIA Waived” Means

Under the Clinical Laboratory Improvement Amendments ( CLIA ), tests are categorized by complexity. Waived tests are those that:

  • Use simple, straightforward methods
  • Carry an insignificant risk of an erroneous result under the CLIA waiver criteria
  • Have been cleared or approved for home use, or meet CLIA waiver criteria for simple laboratory systems

Waived does not mean optional quality. It means the procedure is simple enough that a trained non-pathologist operator can produce reliable results when every labeled step is followed . Common MLA exam traps:

Myth Reality

“Waived = no QC ever” Most systems still require manufacturer-specified QC (on-board checks, external liquid QC, or both)

  • “Anyone can run it without training” Facilities require documented training and competency
  • “You can tweak timing if the line is faint” Never alter timing, volume, or read window to force a result
  • “Waived results don’t need patient ID” Two identifiers still apply before collection and testing

Point-of-care (POC) describes where testing happens (bedside, clinic, ED, outpatient station)—not automatically the CLIA complexity. Many POC devices are waived; some POC platforms are moderate complexity. The MLA works from the facility’s approved menu , package insert, and SOP—not from a memory of “all POC is waived.”

Common Waived / POC Tests the MLA Supports

Exact menus vary by site and CLIA certificate. Frequently tested examples on MLA outlines and workflows:

Test / system Typical specimen MLA focus

Blood glucose meter Capillary whole blood (fingerstick) or approved venous whole blood Code chip/strip lot match, coding if required, correct strip lot, hand hygiene, site prep

Urine dipstick (chemstrip) Fresh urine Timing of each pad, proper immersion, no dripping between pads, room-temp strip storage

Urine hCG (pregnancy) Urine (first morning preferred when sensitivity matters) Correct sample type, read time window, control line validity

Rapid strep / respiratory antigen Throat swab, nasal/NP per IFU Correct swab type, extraction, timing, no early/late reads

FOBT (fecal occult blood) Stool on card or kit Patient prep instructions (diet/meds if required), developer timing, card storage

POC coagulation (when waived) Capillary or whole blood per device Cartridge loading, correct sample volume, no air bubbles

POC HbA1c (when waived) Capillary or whole blood per IFU Cartridge integrity, mixing, analyzer readiness

If a device or kit is not on your waived menu or requires licensed technologist sign-off, do not run it “because the floor asked.” Escalate to the appropriate testing personnel per policy.

Follow the Manufacturer IFU Exactly

The instructions for use (IFU) / package insert is the scientific and regulatory procedure for that product. Your facility SOP should align with the IFU and any validated site adaptations. For the MLA:

Use only approved specimen types (e.g., capillary vs venous; urine vs serum for hCG—do not substitute).

Apply the correct sample volume (fill to the mark; do not overfill cuvettes/cartridges).

Honor all timed steps —incubation, development, meter countdown.

Use matching components —strips, chips, control solutions, and meters designed as a system.

Stop on error codes —do not “retry until it looks good” without following the troubleshooting tree.

Exam-style judgment: if the IFU says “read between 3 and 5 minutes” and the specimen sat for 10 minutes, the result is invalid —repeat with a new device/kit per SOP, do not invent a correction factor.

Reagent and Kit Handling / Storage

Waived kits fail quietly when storage is wrong.

Control point MLA action

Temperature Store kits, strips, controls at the labeled range (often refrigerated or controlled room temperature— check each product )

Equilibration Bring refrigerated reagents to room temperature before use if the IFU requires it; do not test ice-cold strips or urine on cold pads unless allowed

Expiration Do not use expired kits, strips, controls, or developer

Open-vial / open-bottle stability Date vials when opened; discard after open-stability period even if not expired

  • Lot integrity Do not mix strips from different vials into one container; keep desiccant caps closed
  • Visual integrity Discard damaged pouches, discolored strips, cracked cartridges, or kits with broken seals
  • Inventory Rotate stock (FIFO); restock before stockouts force expired product use

Document storage checks when your SOP requires refrigerator logs, room-temperature monitoring, or kit receipt inspection. Link inventory concepts to Chapter 11 inventory management when supplies are ordered and received.

Device Cleaning, Maintenance, and Readiness

POC instruments live in busy clinical areas and pick up blood, dust, and disinfectant residue.

Clean exteriors with manufacturer-approved wipes/solutions only—harsh bleach or alcohol can damage optics, screens, and strip ports if not approved.

Strip ports and cartridge slots must stay free of dried blood and debris; follow cleaning frequency (e.g., daily, after contamination, or per meter prompt).

Batteries and docking: ensure charge, successful data download (if middleware is used), and correct date/time—wrong clock can skew timed QC or connectivity audit trails.

Scheduled maintenance: replace lancet devices per policy, perform meter software updates only as directed by lab leadership, and remove devices from service when error rates rise.

Out-of-service tagging: a meter that fails QC or shows persistent errors is not used for patients until corrected and QC passes.

Operator Competency

CLIA and accrediting bodies expect trained, competent operators for waived testing.

Typical competency elements the MLA should expect and document:

  • Initial training on each device/kit (demo + supervised runs)
  • Written or electronic procedure review
  • Direct observation of patient testing technique and safety
  • Test performance using known samples or QC material
  • Periodic reassessment (often annually, or per facility policy and after method changes)
  • Problem recognition —when to stop, repeat, or escalate

Do not let an untrained float staff member “just run a glucose” on your meter. Competency is person- and method-specific.

Patient Identification Before Testing

POC speed is not an excuse to skip ID. Before fingerstick, urine collection handoff, or swab testing:

Ask the patient to state full name and date of birth (or other second identifier per policy).

Match verbal statements to the wristband , order label, or requisition— two identifiers minimum.

Resolve discrepancies before piercing skin or opening a kit.

Label specimens and enter results under the correct accession/MRN —wrong-patient POC results drive immediate clinical decisions (insulin dosing, admission triage, discharge).

For unconscious or non-verbal patients, use band comparison and dual verification per facility policy—never assume the room number is identity.

Safety and Pre-Analytic Basics at the Bedside

Perform hand hygiene and wear gloves (and other PPE as indicated).

Use single-use lancets ; never recap or share lancing devices between patients.

Clean the puncture site per SOP; allow alcohol to dry before glucose testing when required (wet alcohol can dilute capillary blood).

Dispose of sharps immediately in an approved container.

Handle urine cups and stool cards as biohazardous materials.

Scope of Practice Reminder

The MLA operates and supports waived/POC testing within training and policy. Interpretation beyond the device report (e.g., diagnosing infection from a rapid antigen alone without clinical context, or overriding a critical glucose protocol) belongs to licensed clinicians and laboratory leadership. When results conflict with clinical picture, document and escalate—do not silently discard data.

For hands-on practice scenarios after you study this chapter, use free MLA practice questions at /practice/ascp-mla .